HOYA Corp. Hits Day Low of JPY 27,020 Amid Price Pressure

HOYA Corp., a prominent player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline of 3.16% on March 4, 2026, reaching an intraday low of JPY 27,020.00. This performance comes amid a broader market context where the Japan Nikkei 225 index fell by 1.12% on the same day. Over the past week, HOYA Corp. has seen a more significant drop of 5.35%, contrasting with the Nikkei's slight decline of 0.2%. Despite this recent downturn, the company has demonstrated strong performance over the past year, boasting a remarkable 51.93% increase, outpacing the Nikkei's 46.92% gain. Financially, HOYA Corp. maintains a solid position with a return on equity (ROE) of 21.32% and a low debt-to-equity ratio of -0.55, indicating robust financial health. The company has consistently reported positive results over the last five quarters, with operating cash flow reaching its highest at JPY 251,609 million. As a large-cap entity with a market capitalization of JPY 8,689,580 million, HOYA Corp. continues to be a significant player in its industry.